Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Registry of Patients With Rheumatoid Arthritis Exposed to Golimumab (Go-Compl-Ar): Review and Analysis of Compliance in Colombia

NCT02414984 is registered in ClinicalTrials.gov with Janssen-Cilag, S.A. as lead sponsor.

NCT NCT02414984
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02414984 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Registry of Patients With Rheumatoid Arthritis Exposed to Golimumab (Go-Compl-Ar): Review and Analysis of Compliance in Colombia
Lead sponsor
Janssen-Cilag, S.A.
Phase
Observational
Overall status
Terminated
Start date
March 31, 2015
Completion date
November 30, 2016
Enrollment
37 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis